Table 1.
Baseline characteristics.
Fig 1.
Cumulative overall survival rate of patients with BCLC A or B1.
(A) Cumulative overall survival rate of patients with BCLC A or B1 (B) Respective cumulative overall survival rates of patients with BCLC A1, A2, A3 and B1.
Fig 2.
Cumulative overall survival rate of each subgrouping.
(A) Overall survival rates according to subgrouping 1 (A1 + A2 + A3 vs. B1) (B) Overall survival rates according to subgrouping 2 (A1 + A2 vs. A3 + B1).
Fig 3.
Overall survival of patients with liver cirrhosis (A) and those without liver cirrhosis (B) at baseline.
Fig 4.
Cumulative overall survival rate of each subgrouping after IPW.
(A) Overall survival rates according to subgrouping 1 (A1 + A2 + A3 vs. B1) after IPW (B) Overall survival rates according to subgrouping 2 (A1 + A2 vs. A3 + B1) after IPW.
Fig 5.
Overall survival of patients who underwent surgical resection (A) and those who underwent transarterial chemoembolization (B) as an initial HCC treatment.
Table 2.
Cox proportional hazard regression analysis for overall survival.
Table 3.
Assessment of discrimination ability of respective subgroupings.
Fig 6.
Cumulative overall survival rate of each subgrouping when other intermediate tumors (B2–B4) were taken into consideration.
(A) Overall survival rates according to subgrouping ‘A1–A3 vs. B1–B4’ (B) Overall survival rates according to subgrouping ‘A1–A2 vs. A3–B4’.